Travere Therapeutics Announces Interim Analysis from the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan) in IgA Nephropathy Published in The Lancet and Presented at World Congress of Nephrology 2023
April 01, 2023 04:30 ET | Travere Therapeutics, Inc.
SAN DIEGO, April 01, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced publication in The Lancet of the interim analysis of efficacy and safety data from the ongoing...
Deep Medicine Acquisition Corp. and TruGolf, Inc. Announce the Execution of a Definitive Merger Agreement
March 31, 2023 22:03 ET | Deep Medicine Acquisition Corp.
TruGolf, Inc. (“TruGolf”) will become a public company to further advance its software business and increase manufacturing and sales of its golf simulator technology in the United States and...
Li Auto Inc. March 2023 Delivery Update
March 31, 2023 22:00 ET | Li Auto Inc.
BEIJING, China, April 01, 2023 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that the Company...
AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct Offering
March 31, 2023 21:06 ET | AnPac Bio-Medical Science Co., Ltd.
New York, NY, March 31, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer...
WhatsApp Image 2023-03-31 at 20.15.07
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
March 31, 2023 20:00 ET | InterCure Ltd.
Record fiscal year 2022 revenue of $150 million Record fiscal year 2022 Adjusted EBITDA* of $32 million Record fiscal year 2022 net income of $17 million Generated $20 Million cash flow from...
IMAC Holdings Reports Year End 2022 Financial Results and Corporate Update
March 31, 2023 20:00 ET | IMAC Holdings, Inc.
Revenue increased 14% annually driven by greater adoption of medical treatments. BRENTWOOD, Tenn., March 31, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a...
Belite-Bio-Logo Digital-Full-Color.png
Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results
March 31, 2023 19:03 ET | Belite Bio, Inc
12-month interim data from the ongoing 2-year, Phase 2 Stargardt disease (STGD1) study continues to show halting or slowing of lesion growth; 18-month efficacy and safety update expected during the...
Aridis Provides Corporate Update
March 31, 2023 19:00 ET | Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., March 31, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on...
abvc-logo-nasdaq-440x386 (1).png
ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results
March 31, 2023 18:49 ET | ABVC BioPharma, Inc.
FREMONT, CA, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (Nasdaq: ABVC), a biotechnology company specializing in botanically based solutions that seeks to deliver...
Golar LNG Limited - Announcement of filing of Form 20-F Annual Report
March 31, 2023 18:37 ET | Golar LNG
Golar LNG Limited announces that it has filed its Form 20-F for the year ended December 31, 2022 with the Securities and Exchange Commission in the U.S. Form 20-F can be downloaded from the link...